FASLG and neoplasm: We could, therefore, hypothesize that CTCs co-expressing Fas and FasL may constitute an aggressive subset that would be resistant to apoptosis evoked by FasL-expressing tumor-specific immune cells and, at the same time, could induce apoptosis in Fas-expressing immune cells; however, this hypothesis lacks functional validation.